DRIVE project deliverables
The page lists 35 deliverables related to the research project "DRIVE".
List of Deliverables
| title and desprition | type | last update |
|---|---|---|
Governance Standard Operating Procedures (SOP)This report will be co-led by IRD and SP. Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2016-09-06 |
Documents, reports | 2020-01-14 |
Web-based survey amongst layer 1 stakeholdersCo-led by THL and SEQIRUS. Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2016-09-06 |
Documents, reports | 2019-11-20 |
Report on the Governance SOP implementationReport on the implementation of D1.2 co-led by IRD and SP Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2016-09-06 |
Documents, reports | 2019-11-20 |
Report on synergies identified and collaborations developed with other initiativesThis deliverable will be updated on M60. Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2016-09-06 |
Documents, reports | 2019-11-20 |
Updated and developed protocol for type- and brand- specific IVESThis report will have periodic updates on M11, M23 and M35 Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2016-09-06 |
Documents, reports | 2019-11-20 |
Report on feasible novel and innovative approaches for measuring influenza VEThis deliverable will have periodic updates Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2016-09-06 |
Documents, reports | 2019-11-20 |
Report on the collected feed-back from “layer 1†[…]Report co-led by THL and SEQIRUS. It will be submmited in M14 and will have periodic updates. Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2016-09-06 |
Documents, reports | 2019-11-20 |
First seasonal final report of conducted studiesFinal report on the analysis of the seasonal results to be produced annually Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2016-09-06 |
Documents, reports | 2019-11-20 |
Updated protocol for type- and brand- specific influenza vaccine effectiveness studies (population-based database studies)This deliverable will have periodic updates on M11, M23 and M35. Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2016-09-06 |
Documents, reports | 2019-11-20 |
Communication report of the study milestones arising from WP7 for the use of “layer 1†stakeholdersThis deliverable will have periodic updates on M30, 42 and 60. Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2016-09-06 |
Documents, reports | 2019-11-20 |
Annual tender for influenza vaccine effectiveness study conductThis report will be led by FISABIO and GSK, submmitted in M16 and updated on M28 and M40 Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2016-09-06 |
Documents, reports | 2019-11-20 |
Methodology guidelines for concerted analysis of data and control of confounding factorsThis report will be led by P95 together ABBOT. It will be submmitted in M4 and updated on M55. Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2016-09-06 |
Documents, reports | 2019-11-20 |
Points to consider document on the interpretation of VE resultsThis report will also be co-led by P95 and ABBOT, submmitted in M12 annually updated. Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2016-09-06 |
Documents, reports | 2019-11-20 |
Project HandbookProject Handbook Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2016-09-06 |
Documents, reports | 2019-11-20 |
Generic SAPThis deliverables will be led by P95 and ABBOT. Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2016-09-06 |
Documents, reports | 2019-11-20 |
IT infrastructure to receive and analyse the dataThis deliverables will be led by P95. Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2016-09-06 |
Websites, patent fillings, videos etc. | 2019-11-20 |
Report on the sources for usage of specific influenza vaccine brands and accessibilityThis report will be led by P95 and SEQIRUS, submmitted in M6 and periodically updated Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2016-09-06 |
Documents, reports | 2019-11-20 |
Report with the definition of the ethics policies handbooks collectionThis deliverable will be co-led by FISABIO and SYNAPSE Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2016-09-06 |
Documents, reports | 2019-11-20 |
Generic DMPThis deliverables will be co-led by P95 and ABBOT. It will be submmitted in M6 and updated on M30 and M60 (separate deliverables). Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2016-09-06 |
Documents, reports | 2019-11-20 |
Standard Operating Procedures (SOPs) and templatesDeliverables co-led by SURREY and GSK. It will be submmited in month 8 and annually updated. Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2016-09-06 |
Documents, reports | 2019-11-20 |
Multi Stake-holder Research AgendaThis deliverable will be co-led by IRD and SP. Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2016-09-06 |
Documents, reports | 2019-11-20 |
SWOT analysis plan and list of quality criteriaThis deliverable will be co-led by ISS and SEQIRUS Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2016-09-06 |
Documents, reports | 2019-11-20 |
Report on the comparison of adapted local protocols and Ethical Committee evaluation in each study siteThis report will be led by UNIFI and SEQIRUS, submmited in M12 and it will have periodic updates Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2016-09-06 |
Documents, reports | 2019-11-20 |
Report templatesThis report will be led by P95 and ABBOT, submmitted in M8 periodically updated in M15, M27, M39 and M59. Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2016-09-06 |
Documents, reports | 2019-11-20 |
Communication of a detailed stakeholder map for the DRIVE projectDeliverable co-led by THL and SEQIRUS Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2016-09-06 |
Documents, reports | 2019-11-20 |
Report on the brand availability and usage of specific influenza vaccine brandsThis report will be co-led by ISS and SEQIRUS, submmited in M12 and periodically updated. Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2016-09-06 |
Documents, reports | 2019-11-20 |
Development of the communications planDeliverable co-led by THL and SEQIRUS. It will be submmitted in M12 and will have periodic updates. Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2016-09-06 |
Documents, reports | 2019-11-20 |
Guideline for the identification of vaccine status and vaccine used in study participantsThis deliverable will be co-led by FISABIO and GSK. It will be submmitted in M16 and will have periodic updates. Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2016-09-06 |
Documents, reports | 2019-11-20 |
Report of the results of a systematic analysis on existing initiatives, tools, and/or study protocols for determining IVE […]Lead participants of this report will be FISABIO and GSK. Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2016-09-06 |
Documents, reports | 2019-11-20 |
Electronic study support applicationLead participants of this delivable will also be FISABIO and GSK Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2016-09-06 |
Websites, patent fillings, videos etc. | 2019-11-20 |
Evaluation reports of how the vaccine effectiveness results could fulfil the new regulatory requirementsThe lead beneficiaries of this deliverable will be IABS-EU and SEQIRUS. It will be delivered in M15 and annually updated. Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2016-09-06 |
Documents, reports | 2019-11-20 |
Written report on quality and feasibility evaluationThis deliverables will be led by ISS and SEQIRUS. It will be submmitted in M14 and periodically updated. Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2016-09-06 |
Documents, reports | 2019-11-20 |
Agreement on communications governance modelDeliverable co-led by THL and SEQIRUS Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2016-09-06 |
Documents, reports | 2019-11-20 |
Tailored, timely seasonal summaries of VE results for different stakeholder/clients in layer 1 and 2This deliverable will have periodic updates on M20, 30, 42, 60. Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2016-09-06 |
Documents, reports | 2019-11-20 |
Periodical back-to-back Forum of key stakeholders […]Deliverable co-led by THL and IABS-EU. Programme: H2020-EU.3.1.7. - Topic(s): IMI2-2016-09-06 |
Documents, reports | 2019-11-20 |